BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 27175891)

  • 1. Long-term follow-up of neoplastic pancreatic cysts without high-risk stigmata: how often do we change treatment strategy because of malignant transformation?
    Lekkerkerker SJ; Besselink MG; Busch OR; Dijk F; Engelbrecht MR; Rauws EA; Fockens P; van Hooft JE
    Scand J Gastroenterol; 2016 Sep; 51(9):1138-43. PubMed ID: 27175891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of asymptomatic pancreatic cysts in clinical practice: A vignette questionnaire.
    Hol L; Bruno MJ; Cahen DL
    Pancreatology; 2016; 16(3):416-22. PubMed ID: 26973156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
    Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
    Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of suspected pancreatic cystic neoplasms based on cyst size.
    Walsh RM; Vogt DP; Henderson JM; Hirose K; Mason T; Bencsath K; Hammel J; Brown N
    Surgery; 2008 Oct; 144(4):677-84; discussion 684-5. PubMed ID: 18847654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic lesions and intraductal neoplasms of the pancreas.
    Fasanella KE; McGrath K
    Best Pract Res Clin Gastroenterol; 2009; 23(1):35-48. PubMed ID: 19258185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct Intraductal Papillary Mucinous Neoplasms Predict Malignancy.
    Kwong WT; Lawson RD; Hunt G; Fehmi SM; Proudfoot JA; Xu R; Giap A; Tang RS; Gonzalez I; Krinsky ML; Savides TJ
    Dig Dis Sci; 2015 Sep; 60(9):2800-6. PubMed ID: 25924899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.
    Kayal M; Luk L; Hecht EM; Do C; Schrope BA; Chabot JA; Gonda TA
    AJR Am J Roentgenol; 2017 Aug; 209(2):320-326. PubMed ID: 28590817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients.
    Liu K; Joshi V; van Camp L; Yang QW; Baars JE; Strasser SI; McCaughan GW; Majumdar A; Saxena P; Kaffes AJ
    World J Gastroenterol; 2017 Dec; 23(48):8526-8532. PubMed ID: 29358860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines.
    Smith AL; Abdul-Karim FW; Goyal A
    Cancer Cytopathol; 2016 Apr; 124(4):285-93. PubMed ID: 26618476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management.
    Leung KK; Ross WA; Evans D; Fleming J; Lin E; Tamm EP; Lee JH
    Ann Surg Oncol; 2009 Oct; 16(10):2818-24. PubMed ID: 19536601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of incidental branch-duct intraductal papillary mucinous neoplasms of the pancreas: A study with magnetic resonance imaging cholangiopancreatography.
    Girometti R; Pravisani R; Intini SG; Isola M; Cereser L; Risaliti A; Zuiani C
    World J Gastroenterol; 2016 Nov; 22(43):9562-9570. PubMed ID: 27920477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does cyst growth predict malignancy in branch duct intraductal papillary mucinous neoplasms? Results of a large multicenter experience.
    El Chafic A; El Hajj II; DeWitt J; Schmidt CM; Siddiqui A; Sherman S; Aggarwal A; Al-Haddad M
    Dig Liver Dis; 2018 Sep; 50(9):961-968. PubMed ID: 29866630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.
    Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST
    Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome.
    Lekkerkerker SJ; Besselink MG; Busch OR; Verheij J; Engelbrecht MR; Rauws EA; Fockens P; van Hooft JE
    Gastrointest Endosc; 2017 May; 85(5):1025-1031. PubMed ID: 27693645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
    Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
    Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Khannoussi W; Vullierme MP; Rebours V; Maire F; Hentic O; Aubert A; Sauvanet A; Dokmak S; Couvelard A; Hammel P; Ruszniewski P; Lévy P
    Pancreatology; 2012; 12(3):198-202. PubMed ID: 22687372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.
    Daudé M; Muscari F; Buscail C; Carrère N; Otal P; Selves J; Buscail L; Bournet B
    World J Gastroenterol; 2015 Mar; 21(9):2658-67. PubMed ID: 25759534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
    Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.